China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Rang in aandelen
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Aandeelprijs
$3.74
Marktkapitalisatie
$6.23B
Verandering (1 dag)
-2.11%
Verandering (1 jaar)
-8.54%
Land
CN
Handel China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Categorie
Healthcare
Operationele marge voor China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Operationele marge op October 2026 TTM: 14.59%
Volgens de meest recente financiële rapporten en aandelenkoers van China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is de huidige operationele marge (TTM) 14.59%. Eind 2024 had het bedrijf een operationele marge van 16.20%.
Geschiedenis van de operationele marge van China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. van 2001 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 14.59% | -4.95% |
| 2025 | 15.35% | -5.25% |
| 2024 | 16.20% | 6.79% |
| 2023 | 15.17% | -6.93% |
| 2022 | 16.30% | 2.52% |
| 2021 | 15.90% | 4.74% |
| 2020 | 15.18% | -10.71% |
| 2019 | 17.00% | 33.96% |
| 2018 | 12.69% | -6.55% |
| 2017 | 13.58% | -4.90% |
| 2016 | 14.28% | -21.80% |
| 2015 | 18.26% | 8.18% |
| 2014 | 16.88% | -8.31% |
| 2013 | 18.41% | 1.21% |
| 2012 | 18.19% | 8.47% |
| 2011 | 16.77% | -23.95% |
| 2010 | 22.05% | 20.89% |
| 2009 | 18.24% | 24.00% |
| 2008 | 14.71% | 53.55% |
| 2007 | 9.58% | 6.44% |
| 2006 | 9.00% | 38.25% |
| 2005 | 6.51% | -124.66% |
| 2004 | -26.40% | -352.39% |
| 2003 | 10.46% | 22.05% |
| 2002 | 8.57% | 26.22% |
| 2001 | 6.79% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 19.41% | -98.67% |
DE
|
|
| 19.68% | -98.65% |
DE
|
|
| 10.52% | -99.28% |
JP
|
|
| 17.08% | -98.83% |
CH
|
|
| 22.93% | -98.43% |
IN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.